You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 240 No. 7, August 18, 1978 TABLE OF CONTENTS
  JAMA
  •  Online Features
  ORIGINAL CONTRIBUTIONS
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Malignant Neoplasms Following Cardiac Transplantation

John G. Krikorian, MD; Jeffrey L. Anderson, MD; Charles P. Bieber, MD; Israel Penn, MD; Edward B. Stinson, MD

JAMA. 1978;240(7):639-643.


Abstract

Between Jan 6, 1968, and April 11, 1977, 124 patients underwent cardiac transplantation at Stanford University Medical Center, with a mean and median period of follow-up of 18.3 and 9.7 months, respectively. Malignant neoplasms developed in seven patients—three lymphoproliferative neoplasms, two skin cancers, one acute leukemia, and one colon carcinoma. Visceral tumors were often fatal and caused 11% of deaths after three months following transplantation. The incidence and spectrum of malignant neoplasms in this population are similar to those observed in recipients of renal homografts.

(JAMA 240:639-643, 1978)



Author Affiliations

From the Divisions of Oncology (Dr Krikorian) and Cardiology (Dr Anderson), and Department of Cardiovascular Surgery (Drs Bieber and Stinson), Stanford University School of Medicine, Stanford, Calif; and Department of Surgery (Dr Penn), University of Colorado Medical School, and Denver Veterans Administration Hospital (Dr Penn), Denver.


Footnotes

Reprint requests to Cardiology Division, Stanford University Medical Center, Stanford, CA 94305 (Dr Anderson).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Heart Transplantation
Bethea et al.
Card Surg Adult 2003;2:1427-1460.
FULL TEXT  

Posttransplant primary CNS lymphoma
Phan et al.
Neuro Oncol Duke 2000;2:229-238.
ABSTRACT  

Emerging treatments in multiple sclerosis: Azathioprine and Mof etil
Confavreux and Moreau
Mult Scler 1996;1:379-384.
ABSTRACT  

Solid Tumors After Heart Transplantation: Lethality of Lung Cancer
Pham et al.
Ann. Thorac. Surg. 1995;60:1623-1626.
ABSTRACT | FULL TEXT  

De Novo Solid Malignancies After Cardiac Transplantation
Goldstein et al.
Ann. Thorac. Surg. 1995;60:1783-1789.
ABSTRACT | FULL TEXT  

Second Lymphoid Malignant Neoplasms Occurring in Patients Treated for Hodgkin's Disease
Armitage et al.
Arch Intern Med 1983;143:445-450.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1978 American Medical Association. All Rights Reserved.